Anti-GD2 ADC M3554 in Advanced Solid Tumors

NCT06641908 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: M3554

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]